Remdesivir no COVID-19 silver bullet, says UN health agency
An advisory body of the UN health agency is not recommending the use of the high-profile antiviral drug Remdesivir for hospitalized COVID-19 patients, saying on Thursday there is insufficient evidence that it improves survival outcomes or cuts down on the need for patients to be put onto ventilators.
Read Original Article: Remdesivir no COVID-19 silver bullet, says UN health agency »
